Authors:
THODEN WR
DRUCE HM
FUREY SA
LOCKHART EA
RATNER P
HAMPEL FC
VANBAVEL J
Citation: Wr. Thoden et al., BROMPHENIRAMINE MALEATE - A DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON WITH TERFENADINE FOR SYMPTOMS OF ALLERGIC RHINITIS, American journal of rhinology, 12(4), 1998, pp. 293-299
Authors:
DRUCE HM
THODEN WR
MURE P
FUREY SA
LOCKHART EA
XIE TL
GALANT S
PRENNER BM
WEINSTEIN S
ZIERING R
BRANDON ML
Citation: Hm. Druce et al., BROMPHENIRAMINE, LORATADINE, AND PLACEBO IN ALLERGIC RHINITIS - A PLACEBO-CONTROLLED COMPARATIVE CLINICAL-TRIAL, Journal of clinical pharmacology, 38(4), 1998, pp. 382-389
Authors:
KLEIN GL
LITTLEJOHN T
LOCKHART EA
FUREY SA
Citation: Gl. Klein et al., BROMPHENIRAMINE, TERFENADINE, AND PLACEBO IN ALLERGIC RHINITIS, Annals of allergy, asthma, & immunology, 77(5), 1996, pp. 365-370
Citation: Gl. Klein et Ea. Lockhart, NONPRESCRIPTION BROMPHENIRAMINE MALEATE (BF) VS TERFENADINE (T) IN TREATING SYMPTOMATIC ALLERGIC RHINITIS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 170-170
Citation: Ea. Lockhart et al., ANTIPRURITIC ACTIVITY OF COAL-TAR SOLUTION 9-PERCENT (CT), MENTHOL 1.5-PERCENT (MEN), AND CT MEN IN DANDRUFF-ASSOCIATED PRURITUS/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 183-183
Authors:
LOCKHART EA
FUREY SA
THODEN WR
FISCHER EM
Citation: Ea. Lockhart et al., A DOUBLE-BLIND ENDOSCOPIC EVALUATION OF NAPROXEN (N) AND NONPRESCRIPTION IBUPROFEN (I), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 185-185
Authors:
CHARMAN WN
CHARMAN SA
MONKHOUSE DC
FRISBEE SE
LOCKHART EA
WEISMAN S
FITZGERALD GA
Citation: Wn. Charman et al., BIOPHARMACEUTICAL CHARACTERIZATION OF A LOW-DOSE (75 MG) CONTROLLED-RELEASE ASPIRIN FORMULATION, British journal of clinical pharmacology, 36(5), 1993, pp. 470-473